Time-restricted eating and immune function in women with severe obesity
Official title: Exploring the Effects of Time-restricted Feeding on the Immune Function of Obese Individuals: Multi-omic Approach
Run by Assistance Publique - Hôpitaux de Paris · NCT06899997 · Data updated 2026-11-12
This trial tests whether following an 8-hour time-restricted eating schedule improves immune function in women aged 18–64 with severe obesity compared with a longer, 14-hour eating window, using a healthy lean group for reference.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | Women only |
| Enrollment | 24 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 2 sites (Paris and 1 other locations) |
| Status | Recruiting |
| Started | November 3, 2025 |
| Main results expected | September 15, 2027 |
| Study ends | September 15, 2027 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT06899997 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18–64 with BMI 40–50 kg/m² who have stable weight, a habitual eating window longer than 14 hours, a three-meal pattern, and can attend visits in Paris and read French.
✕Probably not a fit
People with diabetes, major cardiovascular disease, pregnancy, recent cancer, chronic liver or kidney disease, certain medications (anti-inflammatories, antibiotics, immunosuppressants), night-shift work, eating disorders, or chronic viral infections are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional study enrolls women aged 18–64 with severe obesity (BMI 40–50 kg/m²) and a reference group of healthy-weight women. Participants with obesity are randomized to an 8-hour time-restricted feeding window (roughly 6–8 am to 2–4 pm) or a habitual 14-hour eating window, and immune outcomes are compared between groups. The protocol uses deep immune profiling and multi-omics analyses to characterize cellular and molecular changes linked to the feeding schedules. The trial is conducted at HEGP in Paris and requires in-person visits and French social security affiliation.
Why it matters
Potential benefit: If successful, the intervention could improve immune competence and lower inflammation in women with severe obesity, potentially reducing infection risk and related complications.
How similar studies have gone: Small human and animal studies have shown that time-restricted feeding can improve metabolic markers and reduce inflammation, but robust multi-omics evidence on immune function in severe obesity is limited and this approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients with obesity * Women * Age 18-64 years * Body mass Index between 40-50 kg/m² * Self-reported eating pattern window of more than 14h * Three meal eating pattern * Stable body weight (less than 10% of current body weight during the last 3 months) * Social security affiliation * Written consent * Good understanding of the French language Lean patients * Women * Age 18-64 years * Body mass Index between 18.5-24.9 kg/m² * Self-reported eating pattern window of more than 14h * Social security affiliation * Written consent * Good understanding of the French language Exclusion Criteria: * Diabetes type I or II * Major cardiovascular disease * Pregnancy * Medication that could affect the study outcomes (i.e. anti-inflammatory drugs, antibiotics, immunosuppressors) * Use products intended for weight loss * Night work shift * Past record of malignant tumors * Serious liver dysfunction or chronic kidney disease * Eating disorders * Chronic viral disease (Hepatitis B or C, HIV) or inflammatory systemic diseases (i.e. Crohn's disease, rheumatoid arthritis) * Serious cardiovascular or cerebrovascular disease within 6 months before randomization * Severe gastrointestinal diseases or gastrointestinal surgery in the 12 months before randomization * Under guardianship, curatorship, deprived of liberty * Unable or unwilling to sign the informed consent form. * Patient on AME (state medical aid)
Where it's running
-
HEGP - nutrition department
Paris, France Recruiting -
HEGP - digestive surgery
Paris, France Active not recruiting
Study contacts
- Study coordinator: Cléo BOURGEOIS
- Email: cleo.bourgeois@aphp.fr
- Phone: 0156095638
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive changes after bariatric surgery using VR Neurotracker and Neuropsi testing
This study will test whether bariatric surgery combined with virtual‑reality Neurotracker sessions improves thinking and memory in adults with morbid obesity scheduled for surgery.
-
Short-term effects of ultra-processed foods on metabolism
This project will test whether a short-term diet high in ultra-processed foods versus a nutrient- and energy-matched low-UPF diet changes appetite and how much adults with BMI 18.5–30 eat.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Improving team-based biopsychosocial training so clinics can deliver recommended obesity care
This project will test two training methods to help clinic teams (primary care clinicians, behavioral health staff, dietitians, and community health workers) deliver USPSTF-recommended obesity care to patients at Federally Qualified Health Centers.
-
See if same day discharge after bariatric surgery is safe for select patients
This trial tests whether people having sleeve gastrectomy or gastric bypass can go home the same day or should stay at least one night, to see if ER visits within a week differ.
-
Evaluating smoking cessation using e-cigarettes and nicotine therapy
This study is testing whether using e-cigarettes or nicotine replacement therapy can help people with obesity who smoke quit smoking and manage their weight better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.